340 related articles for article (PubMed ID: 25749878)
1. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
3. Effects of letrozole on breast cancer micro-metastatic tumor growth in bone and lung in mice inoculated with murine 4T1 cells.
Wang W; Belosay A; Yang X; Hartman JA; Song H; Iwaniec UT; Turner RT; Churchwell MI; Doerge DR; Helferich WG
Clin Exp Metastasis; 2016 Jun; 33(5):475-85. PubMed ID: 27209469
[TBL] [Abstract][Full Text] [Related]
4. Distribution of isoflavones in samples of serum, liver and mammary glands of rats or pigs fed dietary isoflavones.
Gilani GS; Farmer C; Dyck M; Robertson P; Dahiya J; Sepehr E; Fan L; Nicolidakis H; Curran I; Cooke GM
Ann Nutr Metab; 2011; 58(3):171-80. PubMed ID: 21654164
[TBL] [Abstract][Full Text] [Related]
5. Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice.
Ju YH; Fultz J; Allred KF; Doerge DR; Helferich WG
Carcinogenesis; 2006 Apr; 27(4):856-63. PubMed ID: 16399773
[TBL] [Abstract][Full Text] [Related]
6. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
7. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.
Eskra JN; Schlicht MJ; Bosland MC
Prostate; 2019 Feb; 79(2):223-233. PubMed ID: 30345530
[TBL] [Abstract][Full Text] [Related]
8. Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.
Allred CD; Twaddle NC; Allred KF; Goeppinger TS; Churchwell MI; Ju YH; Helferich WG; Doerge DR
J Agric Food Chem; 2005 Nov; 53(22):8542-50. PubMed ID: 16248551
[TBL] [Abstract][Full Text] [Related]
9. Soy isoflavones increase latency of spontaneous mammary tumors in mice.
Jin Z; MacDonald RS
J Nutr; 2002 Oct; 132(10):3186-90. PubMed ID: 12368416
[TBL] [Abstract][Full Text] [Related]
10. Soy for breast cancer survivors: a critical review of the literature.
Messina MJ; Loprinzi CL
J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
[TBL] [Abstract][Full Text] [Related]
11. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
12. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.
Mizunuma H; Kanazawa K; Ogura S; Otsuka S; Nagai H
Oncology; 2002; 62(1):78-84. PubMed ID: 11810047
[TBL] [Abstract][Full Text] [Related]
13. Soybean isoflavones reduce experimental metastasis in mice.
Li D; Yee JA; McGuire MH; Murphy PA; Yan L
J Nutr; 1999 May; 129(5):1075-8. PubMed ID: 10222402
[TBL] [Abstract][Full Text] [Related]
14. Isoflavones in soy flour diet have different effects on whole-genome expression patterns than purified isoflavone mix in human MCF-7 breast tumors in ovariectomized athymic nude mice.
Liu Y; Hilakivi-Clarke L; Zhang Y; Wang X; Pan YX; Xuan J; Fleck SC; Doerge DR; Helferich WG
Mol Nutr Food Res; 2015 Aug; 59(8):1419-30. PubMed ID: 25820259
[TBL] [Abstract][Full Text] [Related]
15. Soy extract inhibits mammary adenocarcinoma growth in a syngeneic mouse model.
Hewitt AL; Singletary KW
Cancer Lett; 2003 Mar; 192(2):133-43. PubMed ID: 12668277
[TBL] [Abstract][Full Text] [Related]
16. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast.
McMichael-Phillips DF; Harding C; Morton M; Roberts SA; Howell A; Potten CS; Bundred NJ
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1431S-1435S. PubMed ID: 9848512
[TBL] [Abstract][Full Text] [Related]
17. The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer.
Brown NM; Belles CA; Lindley SL; Zimmer-Nechemias LD; Zhao X; Witte DP; Kim MO; Setchell KD
Carcinogenesis; 2010 May; 31(5):886-93. PubMed ID: 20110282
[TBL] [Abstract][Full Text] [Related]
18. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
MartÃnez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
20. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
